News 2016-08-06
Porton’s Semi Annual Senior Management Working Conference August 6, 2016
Chongqing, China, August 6, 2016: Porton Fine Chemicals, Ltd. held its semi-annual senior management working conference on August 6, 2016. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed progress made during the first half of FY 2016 and plans for the second half. Porton continues to make robust advances towards its corporate goals and service mission of helping global pharmaceutical companies more efficiently realize best health outcomes for their patients through chemical process innovation and high-quality production of custom APIs and drug intermediates.
Others
More
News 2025-04-16
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).

News 2025-04-11
Porton Newsletter - March 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities